Ratios Revealed: Decoding ARCA biopharma Inc (ABIO)’s Financial Health

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of ARCA biopharma Inc (NASDAQ: ABIO) was $3.33 for the day, down -7.76% from the previous closing price of $3.61. In other words, the price has decreased by -$7.76 from its previous closing price. On the day, 0.21 million shares were traded. ABIO stock price reached its highest trading level at $3.77 during the session, while it also had its lowest trading level at $3.36.

Ratios:

Our analysis of ABIO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 23.19 and its Current Ratio is at 23.19. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ascendiant Capital Markets on February 27, 2018, initiated with a Buy rating and assigned the stock a target price of $2.

On October 09, 2013, Dawson James started tracking the stock assigning a Buy rating and target price of $3.75.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABIO now has a Market Capitalization of 50339636 and an Enterprise Value of 14484786.

Stock Price History:

The Beta on a monthly basis for ABIO is 0.90, which has changed by 0.692683 over the last 52 weeks, in comparison to a change of 0.25510752 over the same period for the S&P500. Over the past 52 weeks, ABIO has reached a high of $4.49, while it has fallen to a 52-week low of $1.56. The 50-Day Moving Average of the stock is -3.08%, while the 200-Day Moving Average is calculated to be 45.40%.

Shares Statistics:

ABIO traded an average of 1.47M shares per day over the past three months and 74170 shares per day over the past ten days. A total of 14.50M shares are outstanding, with a floating share count of 13.57M. Insiders hold about 6.49% of the company’s shares, while institutions hold 79.58% stake in the company. Shares short for ABIO as of 1718323200 were 4139647 with a Short Ratio of 2.82, compared to 1715731200 on 4096113. Therefore, it implies a Short% of Shares Outstanding of 4139647 and a Short% of Float of 39.92.

Most Popular